SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 8:28 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Conversion Duplicate | 3,114,490 | -- | -- | 100% 0 to 3.11M | |
17-Sep-24 8:28 PM View: | Mbx Biosciences, Inc. (MBX) | 16-Sep-24 | Private Purchase Duplicate | 500,000 | $16.00 | $8,000,000.00 | 16% 3.11M to 3.61M | |
25-Jun-24 10:00 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 52% 5.77K to 8.77K | |
24-Apr-24 5:00 PM View: | Korro Bio, Inc. (KRRO) | 22-Apr-24 | Purchase Duplicate | 17,857 | $56.00 | $999,992.00 | 2% 1.07M to 1.09M | |
19-Jul-23 7:10 PM View: | Adventrx Pharmaceuticals Inc. (SVRA) | 17-Jul-23 | Purchase Duplicate | 333,333 | $3.00 | $999,999.00 | 1% 24.14M to 24.47M | |
06-Mar-23 1:47 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 02-Mar-23 | Acquisition (other) | 5,771 | -- | -- | 100% 0 to 5.77K | |
13-Apr-22 5:32 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-22 | Grant | 948,948 | $1.90 | $1,803,000.00 | 100% 0 to 948.95K | |
30-Jun-21 6:06 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
30-Jun-21 6:06 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
07-Feb-06 7:21 PM View: | Medimmune Inc /de (MEDI) | 03-Feb-06 | Option Exercise | 40,000 | $23.85 | $954,200.00 | 100% 0 to 40.0K | |
07-Feb-06 7:21 PM View: | Medimmune Inc /de (MEDI) | 03-Feb-06 | Market Option Sale | 40,000 | $32.59 | $1,303,420.00 | (100%) 40.0K to 0 | (78%) |